Secondary Names Get a Look as Rotation Takes Place
Traders continue to hunt for good action as the gap narrows between extended big-cap stocks and beat-down smaller names.
Index Trends Remain Split
Forward earnings estimates dip as the 10-Year Treasury yield rises.
After Nike's Earnings, I Have a Warning About the Stock
More than the first-quarter revenue miss, the problem was in the company's guidance.
Large-Cap Indexes Rally to Resistance -- And That Could Be Problematic
There is a reasonable possibility, in our view, of the recent rally failing near current levels.
A Bristol-Myers Bounce? Here's How I'd Play It
Keep in mind earnings are scheduled for Oct. 27 along with a $0.49 dividend on Sept. 30.
3 Fundamental Favorites as the V-Shaped Bounce Gathers Steam
Trading action seems to be shifting away from social media-driven names and into stocks with solid fundamentals and charts.
Clinically Speaking: 6 Stocks Behind the Scenes at Drug Trials
Investors are increasingly looking to the companies involved in clinical trials. Here are six favorite names in this space.
Fed Speaks, Taper Timeline, Dot Fantasy, Evergrande, DC Circus, Booster Stocks
It was as if markets heard what they wanted to hear, when it was actually much more simple: markets heard exactly what they had anticipated.
Is This Another V-Shaped Bounce?
Retests of the lows have been quite rare in recent years.
Speculative Trading Action Cools as Fed Takes Center Stage
We will soon see if another V-shape move is in the cards.